Biomarin Pharmaceutical (BMRN) Gross Margin Growth (1y) (2010 - 2026)
Biomarin Pharmaceutical (BMRN) Gross Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 372.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | -511.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -511.00 |
| Dec 31, 2025 | -1,331.00 |
| Sep 30, 2025 | 722.00 |
| Jun 30, 2025 | 14.00 |
| Mar 31, 2025 | -105.00 |
| Dec 31, 2024 | 313.00 |
| Sep 30, 2024 | -325.00 |
| Jun 30, 2024 | 362.00 |
| Mar 31, 2024 | 342.00 |
| Dec 31, 2023 | 594.00 |
| Sep 30, 2023 | 99.00 |
| Jun 30, 2023 | 112.00 |
| Mar 31, 2023 | -19.00 |
| Dec 31, 2022 | -66.00 |
| Sep 30, 2022 | 232.00 |
| Jun 30, 2022 | 226.00 |
| Mar 31, 2022 | 220.00 |
| Dec 31, 2021 | 128.00 |
| Sep 30, 2021 | 1,427.00 |
| Jun 30, 2021 | -252.00 |